Sign In

Antiretroviral Therapy.

HIV Question Bank

Evaluation and Management of Virologic FailureQuestion 9/10

Questions in Topic

A 37-year-old cisgender woman with HIV presents to clinic for follow-up. She has been taking an antiretroviral regimen of raltegravir plus tenofovir DF-emtricitabine for approximately 2 years. On the most recent follow-up visit, the HIV RNA level had increased from undetectable to 1,820 copies/mL.

Which one of the following is TRUE regarding resistance to raltegravir?

Figure 1. Raltegravir Primary and Secondary Resistance Mutations.
Prev  Skip

Sign In or Register Progress Not Saved!
Since you are not signed in, your progress won't be saved.
Question Last Updated
September 22nd, 2023

Steps to Acquire CE for this Question Bank Topic:

1

Answer

Answer all questions
2

Score 80%+

Answer correctly
3

Claim CE

Choose CNE or CME
4

Give Feedback

Complete survey
5

Print Certificate

Obtain proof of CE

This question requires improvement because:


Comment further on how to improve this question or summary:



Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.